We are monitoring the impact of COVID-19 on Lyme Disease Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5293
Share on
Share on

Global Lyme Disease Diagnostics Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Diagnostic Tests, Diagnostic Technologies, End User & Region – Industry Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 5293
Pages: 175

Lyme disease diagnostics market Size (2021 to 2026):

The global Lyme disease diagnostics market size was valued at USD 840.29 Million in 2021 and also projected to reach USD 1151.26 Million by 2026, is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2026.

Lyme disease is a bacterial infection caused by species borrelia; this disease generally spreads in humans through infected tick bites. Symptoms such as depression, fever, fatigue, and skin rashes result from infected people with the disease. It can be treated with antibiotics only if the condition is diagnosed at the early stages of its occurrence. However, if the disease is left untreated, it affects the central nervous system, heart, and joints. The diagnostic technology is used in different laboratories includes lymphocytic transformation tests, urine antigen tests, immunofluorescent staining, and others. The technologies are developing to diagnose Lyme diseases with the help of blood samples. According to the reports of the centers for disease control and prevention, it is reported that the number of cases of tick-borne was 47,743 leading to the adoption of Lyme disease diagnostic tests. 

MARKET DRIVERS 

The global lyme disease diagnostics market is primarily driven by the increasing awareness about the novel techniques to diagnose lyme disease and identifying techniques of chronic Lyme infection from a blood sample.

The availability of these tests will improve the accuracy issue that pl              agued serology-based assays. The proliferation of Lyme disease is a key factor expected to drive the growth of the target market. Also, market participants' research and development activities are expected to boost the Lyme disease diagnostics market's growth potential.

Furthermore, the expanding government initiatives to upgrade medical healthcare facilities would aid the market's growth in the coming years. Besides, the rising number of tick-borne infectious illnesses, growing occurrences of novel forms of vector-borne diseases, and increasing healthcare spending are likely to propel the worldwide Lyme disease diagnostics market further. In partnership with the Centers for Disease Control and Prevention (CDC), the National Institute of Allergy and Infectious Diseases plays a critical role in supporting the development of innovative approaches to enhance Lyme disease screening. Moreover, NIAID grantees collaborate with the Centers for Disease Control and Prevention (CDC). However, leading market players are engaged in the research and development of novel tests for Lyme disease diagnosis, which is projected to help the global Lyme disease diagnostics market's growth. Many individuals with Lyme-like symptoms are misdiagnosed because current serological assays cannot reliably detect antibodies to all borrelia burgdorferi strains. As a result, there is a growing demand for improved illness diagnostic tests.

MARKET RESTRAINS:

However, global Lyme disease diagnostics market expansion is constrained by a lack of public awareness about the condition and ineffective Lyme disease testing in undeveloped and emerging countries. The lack of Lyme disease therapy in rural regions has slowed the Lyme disease diagnostics market over the period.

Impact of COVID-19 on the global lyme disease diagnostics market:

The global pandemic coronavirus-19 (COVID-19) of 2020 has captivated healthcare experts' attention, impacting all aspects of treatment. The front end of all healthcare contacts now includes screening for COVID-19 symptoms (such as respiratory symptoms, fever, myalgia, and exhaustion). Because of COVID-19 pandemic-related changes in healthcare workflow and diagnostic reasoning, Lyme disease diagnosis was delayed in the spring of 2020. During the current COVID-19 epidemic, the COVID-19 outbreak has prompted a significant increase in the use of telemedicine in healthcare services. The effects of telemedicine in identifying acute infectious disorders like Lyme disease are unknown. Provide telemedicine to help diagnose Lyme disease and enable fast access to diagnosis and treatments. But it is expected to result in fewer ambulatory visits to outpatient doctors. A positive symptom screen triggers a prioritized process and evaluation, including COVID-19 testing and quarantine, depending on the results. Evaluation for other reasons of the patient's symptoms is frequently postponed throughout the quarantine period, risking delayed diagnosis and consequences. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Diagnostic Tests, Diagnostic Technologies, End User and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This market research report on the global lyme disease diagnostics market has been segmented and sub-segmented into the following categories.

Lyme disease diagnostics market - By Diagnostic Tests:

  • Darkfield Microscopy
  • Urine Antigen Tests
  • Lymphocytic Transformation Test
  • Serological Tests
  • Immunofluorescence Staining
  • PCR Tests

Based on the diagnostic test, the serological test segment is predicted to dominate the global lyme disease diagnostics market during the forecast period due to the frequent practice and routine tests for the laboratories and hospitals to diagnose Lyme disease.

The urine antigen tests segment is another lucrative segment in the global lyme disease diagnostics market and is estimated to register a healthy growth rate during the forecast period. 

Lyme disease diagnostics market - By Diagnostic Technologies:

Based on technologies, the molecular diagnostic segment was the market leader in the global lyme disease diagnostics market in 2020 and is estimated to continue its lead throughout the forecast period. Advanced laboratories for the disease tests and healthcare facilities' availability boost the molecular diagnostic segment during the forecast period. 

Lyme disease diagnostics market - By End User:

  • hospitals/clinics
  • Pharmaceutical Industries
  • Pathology labs
  • Research Institutes

Based on the end-user, the hospitals and clinics segment held the majority share with the increasing CAGR over the forecast years, and it is expected to dominate the market. The available commercial test kits for detecting Lyme diseases are expected to propel the market growth over the forecast period. 

Lyme disease diagnostics market - By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America 
  • The Middle East and Africa

Geographically, the North America Lyme disease diagnostics market is estimated to play the leading role in the global market during the forecast period and is majorly driven by the factors such as addressing the growing prevalence of Lyme diseases, identifying innovative ways of diagnosing Lyme disease, and improving healthcare facilities. Research and development activities on Lyme disease are anticipated to provide opportunities for the players in the North American market. 

The European market is anticipated to be the second-largest regional market globally and is projected to grow at a promising rate during the forecast period. An increase in lyme disease prevalence, growing awareness among people regarding lyme diseases, and increasing investments are expected to drive the European market.

The Asia Pacific market is one of the fastest-growing regional markets globally and is estimated to grow at the highest CAGR during the forecast period. Factors such as the rising prevalence of lyme diseases, the emergence of new lyme diagnostic tests, and the increasing focus on developing healthcare facilities to provide better healthcare treatments for the people in this region are expected to propel the market growth. Rising disposable income in urban areas is also a factor driving the growth rate of the market. 

The Middle East and Africa Lyme disease diagnostics market are expected to register a steady growth rate during the forecast period. The increasing prevalence of Lyme diseases and support by the government to improve healthcare facilities are anticipated to fuel the growth rate of the market in this region.

KEY MARKET PARTICIPANTS: 

Some of the prominent companies operating in the global lyme disease diagnostics market profiled in the report are Boulder Diagnostics, Immunetics Inc., GlaxoSmithKline Pharmaceuticals Ltd, Bio-Rad Laboratories, Alere Inc. (ALR), Roche Diagnostics International Ltd, Graphene Frontiers, Covance Inc., Affymetrix Inc., Siemens AG, Baxter International Inc., and Fresenius Medical Care AG & Co.

1. Introduction         

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                      

        2.2.1 Secondary Research           

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling      

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemiology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Diagnostic Tests

        5.1.1 Introduction           

        5.1.2 Serological tests    

                        5.1.2.1 ELISA (Enzyme-linked Immunosorbent Assay)

                        5.1.2.2 ELFA (Enzyme-linked Fluorescent Immunoassay)

                        5.1.2.3 Western Blot

        5.1.3 Lymphocytic transformation test  

        5.1.4 Immunofluorescence staining        

        5.1.5 PCR Analysis           

        5.1.6 Urine antigen tests              

        5.1.7 Darkfield microscopy         

        5.1.8  Y-o-Y Growth Analysis, By Diagnostic Tests              

        5.1.9  Market Attractiveness Analysis, By Diagnostic Tests            

        5.1.10  Market Share Analysis, By Diagnostic Tests           

                5.2 Diagnostic Technologies

        5.2.1 Introduction           

        5.2.2 Molecular diagnostics         

        5.2.3 Brain MRI 

        5.2.4 Spinal tap 

        5.2.5 Echocardiogram    

        5.2.6 Electrocardiogram

        5.2.7 Monoclonal antibodies      

        5.2.8 Flow cytometry     

        5.2.9 Gel micro droplets               

        5.2.10 Y-o-Y Growth Analysis, By Diagnostic Technologies             

        5.2.11 Market Attractiveness Analysis, By Diagnostic Technologies           

        5.2.12 Market Share Analysis, By Diagnostic Technologies            

                5.3 End Users                    

        5.3.1 Introduction           

        5.3.2 Hospitals / Clinics  

        5.3.3 Pharmaceutical Industries

        5.3.4 Pathology labs       

        5.3.5 Research Institutes             

        5.3.6 Y-o-Y Growth Analysis, By End Users           

        5.3.7  Market Attractiveness Analysis, By End Users        

        5.3.8  Market Share Analysis, By End Users          

6. Geographical Analysis                      

                6.1 Introduction       

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Geographical Area

                        6.1.3.2 By Diagnostic Tests

                        6.1.3.3 By Diagnostic Technologies

                        6.1.3.4 By End Users

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Geographical Area

                        6.1.4.2 By Diagnostic Tests

                        6.1.4.3 By Diagnostic Technologies

                        6.1.4.4 By End Users

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Geographical Area

                        6.1.5.2 By Diagnostic Tests

                        6.1.5.3 By Diagnostic Technologies

                        6.1.5.4 By End Users

                6.2 North America  

        6.2.1 Introduction           

        6.2.2 United States         

        6.2.3 Canada     

                6.3 Europe

        6.3.1 Introduction           

        6.3.2 U.K             

        6.3.3 Spain         

        6.3.4 Germany 

        6.3.5 Italy            

        6.3.6 France       

                6.4 Asia-Pacific                 

        6.4.1 Introduction           

        6.4.2 China         

        6.4.3 India          

        6.4.4 Japan         

        6.4.5 Australia   

        6.4.6 South Korea           

                6.5 Latin America     

        6.5.1 Introduction           

        6.5.2 Brazil          

        6.5.3 Argentina

        6.5.4 Mexico     

        6.5.5 Rest of Latin America          

                6.6 Middle East & Africa       

        6.6.1 Introduction           

        6.6.2 Middle-East            

        6.6.3 Africa         

7. Strategic Analysis               

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental       

                7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services              

        7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                

                8.1 Abbott Laboratories       

        8.1.1 Overview 

        8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 Siemens AG       

                8.3 GlaxoSmithKline Pharmaceuticals Ltd.    

                8.4 Fresenius Medical Care AG & Co.                      

                8.5 Baxter International Inc.                       

                8.6 Affymetrix Inc.  

                8.7 Immunetics Inc.

                8.8 Boulder Diagnostics                

                8.9 Roche Diagnostics International Ltd.                

                8.10 Canon U.S. Life Sciences                     

9. Competitive Landscape                   

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures 

                9.4 New Product Launches 

10. Market Outlook and Investment Opportunities                 

Appendix                   

                a) List of Tables                

                b) List of Figures      

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Lyme Disease Diagnostic  Market By Region, From 2021 to 2026 ( USD Million )
  2. Global Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  3. Global Serological tests Market By Region, From 2021 to 2026 ( USD Million )
  4. Global Lymphocytic transformation test Market By Region, From 2021 to 2026 ( USD Million )
  5. Global Immunofluorescence staining Market By Region, From 2021 to 2026 ( USD Million )
  6. Global PCR Analysis  Market By Region, From 2021 to 2026 ( USD Million )
  7. Global Urine antigen tests Market By Region, From 2021 to 2026 ( USD Million )
  8. Global Dark field microscopy Market By Region, From 2021 to 2026 ( USD Million )
  9. Global Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  10. Global Molecular diagnostics Market By Region, From 2021 to 2026 ( USD Million )
  11. Global Brain MRI Market By Region, From 2021 to 2026 ( USD Million )
  12. Global Spinal tap Market By Region, From 2021 to 2026 ( USD Million )
  13. Global Echocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  14. Global Electrocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  15. Global Monoclonal antibodies Market By Region, From 2021 to 2026 ( USD Million )
  16. Global Flow cytometry Market By Region, From 2021 to 2026 ( USD Million )
  17. Global Gel micro droplets Market By Region, From 2021 to 2026 ( USD Million )
  18. Global Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  19. Global Hospitals / Clinics Market By Region, From 2021 to 2026 ( USD Million )
  20. Global Pharmaceutical Industries Market By Region, From 2021 to 2026 ( USD Million )
  21. Global Pathology labs Market By Region, From 2021 to 2026 ( USD Million )
  22. Global Research Institutes Market By Region, From 2021 to 2026 ( USD Million )
  23. North America Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  24. North America Serological tests Market By Region, From 2021 to 2026 ( USD Million )
  25. North America Lymphocytic transformation test Market By Region, From 2021 to 2026 ( USD Million )
  26. North America Immunofluorescence staining Market By Region, From 2021 to 2026 ( USD Million )
  27. North America PCR Analysis  Market By Region, From 2021 to 2026 ( USD Million )
  28. North America Urine antigen tests Market By Region, From 2021 to 2026 ( USD Million )
  29. North America Dark field microscopy Market By Region, From 2021 to 2026 ( USD Million )
  30. North America Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  31. North America Molecular diagnostics Market By Region, From 2021 to 2026 ( USD Million )
  32. North America Brain MRI Market By Region, From 2021 to 2026 ( USD Million )
  33. North America Spinal tap Market By Region, From 2021 to 2026 ( USD Million )
  34. North America Echocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  35. North America Electrocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  36. North America Monoclonal antibodies Market By Region, From 2021 to 2026 ( USD Million )
  37. North America Flow cytometry Market By Region, From 2021 to 2026 ( USD Million )
  38. North America Gel micro droplets Market By Region, From 2021 to 2026 ( USD Million )
  39. North America Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  40. North America Hospitals / Clinics Market By Region, From 2021 to 2026 ( USD Million )
  41. North America Pharmaceutical Industries Market By Region, From 2021 to 2026 ( USD Million )
  42. North America Pathology labs Market By Region, From 2021 to 2026 ( USD Million )
  43. North America Research Institutes Market By Region, From 2021 to 2026 ( USD Million )
  44. United States Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  45. United States Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  46. United States Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  47. Canada Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  48. Canada Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  49. Canada Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  50. Europe Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  51. Europe Serological tests Market By Region, From 2021 to 2026 ( USD Million )
  52. Europe Lymphocytic transformation test Market By Region, From 2021 to 2026 ( USD Million )
  53. Europe Immunofluorescence staining Market By Region, From 2021 to 2026 ( USD Million )
  54. Europe PCR Analysis  Market By Region, From 2021 to 2026 ( USD Million )
  55. Europe Urine antigen tests Market By Region, From 2021 to 2026 ( USD Million )
  56. Europe Dark field microscopy Market By Region, From 2021 to 2026 ( USD Million )
  57. Europe Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  58. Europe Molecular diagnostics Market By Region, From 2021 to 2026 ( USD Million )
  59. Europe Brain MRI Market By Region, From 2021 to 2026 ( USD Million )
  60. Europe Spinal tap Market By Region, From 2021 to 2026 ( USD Million )
  61. Europe Echocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  62. Europe Electrocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  63. Europe Monoclonal antibodies Market By Region, From 2021 to 2026 ( USD Million )
  64. Europe Flow cytometry Market By Region, From 2021 to 2026 ( USD Million )
  65. Europe Gel micro droplets Market By Region, From 2021 to 2026 ( USD Million )
  66. Europe Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  67. Europe Hospitals / Clinics Market By Region, From 2021 to 2026 ( USD Million )
  68. Europe Pharmaceutical Industries Market By Region, From 2021 to 2026 ( USD Million )
  69. Europe Pathology labs Market By Region, From 2021 to 2026 ( USD Million )
  70. Europe Research Institutes Market By Region, From 2021 to 2026 ( USD Million )
  71. U.K. Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  72. U.K. Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  73. U.K. Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  74. Germany Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  75. Germany Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  76. Germany Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  77. France Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  78. France Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  79. France Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  80. Italy Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  81. Italy Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  82. Italy Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  83. Spain Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  84. Spain Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  85. Spain Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  86. Asia Pacific Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  87. Asia Pacific Serological tests Market By Region, From 2021 to 2026 ( USD Million )
  88. Asia Pacific Lymphocytic transformation test Market By Region, From 2021 to 2026 ( USD Million )
  89. Asia Pacific Immunofluorescence staining Market By Region, From 2021 to 2026 ( USD Million )
  90. Asia Pacific PCR Analysis  Market By Region, From 2021 to 2026 ( USD Million )
  91. Asia Pacific Urine antigen tests Market By Region, From 2021 to 2026 ( USD Million )
  92. Asia Pacific Dark field microscopy Market By Region, From 2021 to 2026 ( USD Million )
  93. Asia Pacific Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  94. Asia Pacific Molecular diagnostics Market By Region, From 2021 to 2026 ( USD Million )
  95. Asia Pacific Brain MRI Market By Region, From 2021 to 2026 ( USD Million )
  96. Asia Pacific Spinal tap Market By Region, From 2021 to 2026 ( USD Million )
  97. Asia Pacific Echocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  98. Asia Pacific Electrocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  99. Asia Pacific Monoclonal antibodies Market By Region, From 2021 to 2026 ( USD Million )
  100. Asia Pacific Flow cytometry Market By Region, From 2021 to 2026 ( USD Million )
  101. Asia Pacific Gel micro droplets Market By Region, From 2021 to 2026 ( USD Million )
  102. Asia Pacific Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  103. Asia Pacific Hospitals / Clinics Market By Region, From 2021 to 2026 ( USD Million )
  104. Asia Pacific Pharmaceutical Industries Market By Region, From 2021 to 2026 ( USD Million )
  105. Asia Pacific Pathology labs Market By Region, From 2021 to 2026 ( USD Million )
  106. Asia Pacific Research Institutes Market By Region, From 2021 to 2026 ( USD Million )
  107. Japan Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  108. Japan Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  109. Japan Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  110. China Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  111. China Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  112. China Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  113. India Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  114. India Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  115. India Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  116. Australia Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  117. Australia Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  118. Australia Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  119. South Korea Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  120. South Korea Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  121. South Korea Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  122. Latin America Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  123. Latin America Serological tests Market By Region, From 2021 to 2026 ( USD Million )
  124. Latin America Lymphocytic transformation test Market By Region, From 2021 to 2026 ( USD Million )
  125. Latin America Immunofluorescence staining Market By Region, From 2021 to 2026 ( USD Million )
  126. Latin America PCR Analysis  Market By Region, From 2021 to 2026 ( USD Million )
  127. Latin America Urine antigen tests Market By Region, From 2021 to 2026 ( USD Million )
  128. Latin America Dark field microscopy Market By Region, From 2021 to 2026 ( USD Million )
  129. Latin America Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  130. Latin America Molecular diagnostics Market By Region, From 2021 to 2026 ( USD Million )
  131. Latin America Brain MRI Market By Region, From 2021 to 2026 ( USD Million )
  132. Latin America Spinal tap Market By Region, From 2021 to 2026 ( USD Million )
  133. Latin America Echocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  134. Latin America Electrocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  135. Latin America Monoclonal antibodies Market By Region, From 2021 to 2026 ( USD Million )
  136. Latin America Flow cytometry Market By Region, From 2021 to 2026 ( USD Million )
  137. Latin America Gel micro droplets Market By Region, From 2021 to 2026 ( USD Million )
  138. Latin America Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  139. Latin America Hospitals / Clinics Market By Region, From 2021 to 2026 ( USD Million )
  140. Latin America Pharmaceutical Industries Market By Region, From 2021 to 2026 ( USD Million )
  141. Latin America Pathology labs Market By Region, From 2021 to 2026 ( USD Million )
  142. Latin America Research Institutes Market By Region, From 2021 to 2026 ( USD Million )
  143. Brazil Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  144. Brazil Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  145. Brazil Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  146. Argentina Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  147. Argentina Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  148. Argentina Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  149. Mexico Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  150. Mexico Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  151. Mexico Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  152. Rest of Latin America Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  153. Rest of Latin America Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  154. Rest of Latin America Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  155. Middle East and Africa Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  156. Middle East and Africa Serological tests Market By Region, From 2021 to 2026 ( USD Million )
  157. Middle East and Africa Lymphocytic transformation test Market By Region, From 2021 to 2026 ( USD Million )
  158. Middle East and Africa Immunofluorescence staining Market By Region, From 2021 to 2026 ( USD Million )
  159. Middle East and Africa PCR Analysis  Market By Region, From 2021 to 2026 ( USD Million )
  160. Middle East and Africa Urine antigen tests Market By Region, From 2021 to 2026 ( USD Million )
  161. Middle East and Africa Dark field microscopy Market By Region, From 2021 to 2026 ( USD Million )
  162. Middle East and Africa Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  163. Middle East and Africa Molecular diagnostics Market By Region, From 2021 to 2026 ( USD Million )
  164. Middle East and Africa Brain MRI Market By Region, From 2021 to 2026 ( USD Million )
  165. Middle East and Africa Spinal tap Market By Region, From 2021 to 2026 ( USD Million )
  166. Middle East and Africa Echocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  167. Middle East and Africa Electrocardiogram Market By Region, From 2021 to 2026 ( USD Million )
  168. Middle East and Africa Monoclonal antibodies Market By Region, From 2021 to 2026 ( USD Million )
  169. Middle East and Africa Flow cytometry Market By Region, From 2021 to 2026 ( USD Million )
  170. Middle East and Africa Gel micro droplets Market By Region, From 2021 to 2026 ( USD Million )
  171. Middle East and Africa Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  172. Middle East and Africa Hospitals / Clinics Market By Region, From 2021 to 2026 ( USD Million )
  173. Middle East and Africa Pharmaceutical Industries Market By Region, From 2021 to 2026 ( USD Million )
  174. Middle East and Africa Pathology labs Market By Region, From 2021 to 2026 ( USD Million )
  175. Middle East and Africa Research Institutes Market By Region, From 2021 to 2026 ( USD Million )
  176. Middle East Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  177. Middle East Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  178. Middle East Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )
  179. Africa Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2021 to 2026 ( USD Million )
  180. Africa Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2021 to 2026 ( USD Million )
  181. Africa Lyme Disease Diagnostic  Market By End Users, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample